Promente Clinical Research Center
KOASTAL-3 clinical trial
Exploring new directions in depression treatment.
Study information
KOASTAL-3 is conducted by Neumora Therapeutics (NMRA-335140-303). It is an investigational clinical trial evaluating a new molecule in depression treatment.
Who is this study for?
The study is intended for patients diagnosed with depression who are looking for new pharmacological treatment options under strict specialist supervision.